S Shetty, A Kumar, AR Johnson, S Pueblitz, D Holiday, G Raghu and S Idell
University of Texas Health Science Center at Tyler.

Binding of urokinase-type plasminogen activator (uPA) to a specific receptor (uPAR) on human lung fibroblasts enables it to regulate cellular proteolysis and remodeling of the extracellular matrix. Binding studies with radiolabeled uPA indicated that both normal and fibrotic lung fibroblasts express the receptor, but cells from fibrotic tissues bound significantly more uPA (P < 0.001). Phorbol myristate acetate, lipopolysaccharide, transforming growth factor-beta (TGF- beta), and tumor necrosis factor-alpha (TNF-alpha) increased uPA binding and plasminogen activation at the cell surface, with a greater maximal effect on fibrotic than on normal fibroblasts. Excess unlabeled uPA, specific antibody, or antisense oligonucleotides inhibited uPA binding. Ribonuclease (RNase) protection assays showed higher levels of uPAR messenger ribonuleic acid (mRNA) in each of the five fibrotic cell lines than in normal fibroblasts. uPA was mitogenic for normal as well as fibrotic fibroblasts, indicating that receptor binding concurrently localizes cellular proteolytic activity and stimulates mitogenesis. Morphometry and immunohistochemical analysis showed that uPAR, as well as uPA, was increased in fibroblasts in fibrotic lung tissue. Increased expression of uPAR by fibrotic lung fibroblasts and enhanced urokinase binding induced by proinflammatory cytokines suggest a novel mechanism by which fibroblast-mediated matrix remodeling and proliferation may be regulated in interstitial lung diseases.

This article has been cited by other articles:

				A. A. Eddy and A. B. Fogo Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2999 - 3012. [Full Text] [PDF]

				U. Bartram and C. P. Speer The Role of Transforming Growth Factor {beta} in Lung Development and Disease Chest, February 1, 2004; 125(2): 754 - 765. [Abstract] [Full Text] [PDF]

				J. L. Coleman and J. L. Benach The Urokinase Receptor Can Be Induced by Borrelia burgdorferi through Receptors of the Innate Immune System Infect. Immun., October 1, 2003; 71(10): 5556 - 5564. [Abstract] [Full Text] [PDF]

				G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, P. Carmeliet, and A. A. Eddy Urokinase Receptor Modulates Cellular and Angiogenic Responses in Obstructive Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1234 - 1253. [Abstract] [Full Text] [PDF]

				G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, C. E. Alpers, Y. Liu, P. Carmeliet, and A. A. Eddy Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1254 - 1271. [Abstract] [Full Text] [PDF]

				S. Idell, A. Mazar, D. Cines, A. Kuo, G. Parry, S. Gawlak, J. Juarez, K. Koenig, A. Azghani, W. Hadden, et al. Single-Chain Urokinase Alone or Complexed to Its Receptor in Tetracycline-induced Pleuritis in Rabbits Am. J. Respir. Crit. Care Med., October 1, 2002; 166(7): 920 - 926. [Abstract] [Full Text]

				L. B. Siconolfi and N. W. Seeds Induction of the Plasminogen Activator System Accompanies Peripheral Nerve Regeneration after Sciatic Nerve Crush J. Neurosci., June 15, 2001; 21(12): 4336 - 4347. [Abstract] [Full Text] [PDF]

				L. B. Siconolfi and N. W. Seeds Mice Lacking tPA, uPA, or Plasminogen Genes Showed Delayed Functional Recovery after Sciatic Nerve Crush J. Neurosci., June 15, 2001; 21(12): 4348 - 4355. [Abstract] [Full Text] [PDF]

				S. S. Lakka, R. Rajagopal, M. K. Rajan, P. M. Mohan, Y. Adachi, D. H. Dinh, W. C. Olivero, M. Gujrati, F. Ali-Osman, J. A. Roth, et al. Adenovirus-mediated Antisense Urokinase-Type Plasminogen Activator Receptor Gene Transfer Reduces Tumor Cell Invasion and Metastasis in Non-Small Cell Lung Cancer Cell Lines Clin. Cancer Res., April 1, 2001; 7(4): 1087 - 1093. [Abstract] [Full Text]

				J. L. Coleman, J. A. Gebbia, and J. L. Benach Borrelia burgdorferi and Other Bacterial Products Induce Expression and Release of the Urokinase Receptor (CD87) J. Immunol., January 1, 2001; 166(1): 473 - 480. [Abstract] [Full Text] [PDF]

				S. Shetty and S. Idell Posttranscriptional regulation of plasminogen activator inhibitor-1 in human lung carcinoma cells in vitro Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L148 - L156. [Abstract] [Full Text] [PDF]

				R. C. Perkins, V. Courtney Broaddus, S. Shetty, S. Hamilton, and S. Idell Asbestos Upregulates Expression of the Urokinase-Type Plasminogen Activator Receptor on Mesothelial Cells Am. J. Respir. Cell Mol. Biol., November 1, 1999; 21(5): 637 - 646. [Abstract] [Full Text]

				S. Shetty and S. Idell A urokinase receptor mRNA binding protein from rabbit lung fibroblasts and mesothelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L871 - L882. [Abstract] [Full Text] [PDF]

				C. Lardot, M. Delos, and D. Lison Upregulation of urokinase in alveolar macrophages and lung tissue in response to silica particles Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L1040 - L1048. [Abstract] [Full Text] [PDF]

				C. G. LARDOT, F. A. HUAUX, F. R. BROECKAERT, P. J. DECLERCK, M. DELOS, B. FUBINI, and D. F. LISON Role of Urokinase in the Fibrogenic Response of the Lung to Mineral Particles Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 617 - 628. [Abstract] [Full Text]